M C Lo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M C Lo

Showing results (141-150 of 142) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 142 results.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.

Journal of Medicinal Chemistry|May 27, 2026

Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.

Pageof 15

Search research articles

Showing results (141-150 of 142) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 142 results.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.

Journal of Medicinal Chemistry|May 27, 2026

Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.

Pageof 15